Literature DB >> 1347160

Isolation and characterization of endogenous modulators for GABA system.

M Yarom1, J Bao, X W Tang, E Wu, Y H Lee, W H Tsai, J Y Wu.   

Abstract

Pig brain extracts from both soluble and membrane fractions were found to contain potent inhibitors for GABA synthesizing enzyme, GAD, referred to as endogenous GAD inhibitors (EGIs) and for the binding of GABA agonist, muscimol, referred to as muscimol binding inhibitors (MBIs). EGIs and MBIs were first purified through gel-filtration Bio-Gel P-2 columns, in which multiple activity peaks were observed. One of them appears to be co-eluted with either L-glutamate or GABA. However, others are clearly separated from L-glutamate or GABA. EGIs were found to be low MW (less than 1,800 dalton), heat and acid-base stable, negatively charged, non hydrophobic substances. MBIs were found to be low MW (less than 1,800 dalton) neutral or positively charged substances. MBIs had no effect on [3H]flunitrazepam (FNZP) binding, indicating that they are not endogenous benzodiazepine receptor ligands and they may act specifically on GABA binding site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347160     DOI: 10.1007/bf00966871

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  Monoclonal antibodies and conventional antisera to the GABAA receptor/benzodiazepine receptor/Cl- channel complex.

Authors:  J Vitorica; D Park; G Chin; A L de Blas
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

2.  Purification and characterization of a benzodiazepine-like substance from mammalian brain.

Authors:  C C Liao; H S Lin; J Y Liu; L S Hibbard; J Y Wu
Journal:  Neurochem Res       Date:  1989-04       Impact factor: 3.996

3.  Regional distribution of the GABAA/benzodiazepine receptor (alpha subunit) mRNA in rat brain.

Authors:  P Montpied; B M Martin; S L Cottingham; B K Stubblefield; E I Ginns; S M Paul
Journal:  J Neurochem       Date:  1988-11       Impact factor: 5.372

4.  Kinetically different, multiple forms of glutamate decarboxylase in rat brain.

Authors:  D C Spink; T G Porter; S J Wu; D L Martin
Journal:  Brain Res       Date:  1987-09-22       Impact factor: 3.252

5.  Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase.

Authors:  Y C Chang; D I Gottlieb
Journal:  J Neurosci       Date:  1988-06       Impact factor: 6.167

6.  Properties of brain L-glutamate decarboxylase: inhibition studies.

Authors:  J Y Wu; E Roberts
Journal:  J Neurochem       Date:  1974-10       Impact factor: 5.372

7.  Isolation and identification in bovine cerebral cortex of n-butyl beta-carboline-3-carboxylate, a potent benzodiazepine binding inhibitor.

Authors:  C Peña; J H Medina; M L Novas; A C Paladini; E De Robertis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 8.  Molecular biology of GABAA receptors.

Authors:  R W Olsen; A J Tobin
Journal:  FASEB J       Date:  1990-03       Impact factor: 5.191

9.  Structure and function of L-glutamate decarboxylase.

Authors:  J Y Wu; W M Huang; L Reed-Fourquet; J Bao; B Nathan; E Wu; W H Tsai
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

10.  Two forms of rat brain glutamic acid decarboxylase differ in their dependence on free pyridoxal phosphate.

Authors:  L A Denner; J Y Wu
Journal:  J Neurochem       Date:  1985-03       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.